Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Study of Chronic Pancreatitis and the Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00782795
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:42.238953+00:00
Published At
2017-12-11T00:00:00+00:00
Record Updated At
2018-01-11
Results Posted At
2017-12-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Chronic Pancreatitis", "Insulin Resistance", "Normal or Mildly Abnormal Stool Fat Levels"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-01-11"
protocolSection.identificationModule.nctId
"NCT00782795"
protocolSection.identificationModule.officialTitle
"Phase II Study of Chronic Pancreatitis and the Effect of Pioglitazone on Endocrine Function, Exocrine Function \u0026 Structure, Pain \u0026 Life Quality"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-12-11"

Study condition terms

  • Chronic Pancreatitis (protocolSection.conditionsModule.conditions)
  • Insulin Resistance (protocolSection.conditionsModule.conditions)
  • Normal or Mildly Abnormal Stool Fat Levels (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.